Skip to content
value.today

NovaBridge Biosciences vs Moderna, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $177 M for NovaBridge Biosciences, 509 times as much (market caps of Jan 5, 2024 for NovaBridge Biosciences and Oct 30, 2026 for Moderna, Inc.). NovaBridge Biosciences's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Both made a net loss: $46 M for NovaBridge Biosciences and $2.8 B for Moderna, Inc.
  • Moderna, Inc. employs more people: 4,700 against 228 at NovaBridge Biosciences.

Market value, the same start = 100

From Jan 2021: how each one's value moved, whatever its size.

055109164218202120222023202420252026NovaBridge Biosciences 5Moderna, Inc. 218

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B201720182019202020212022202320242025NovaBridge Biosciences $0BModerna, Inc. $2B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureNovaBridge Biosciences
NBP
Moderna, Inc.
MRNA · #274 in the world
Profile
Country🇨🇳 China🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded—2010
Size
Market cap$177 M*$90.1 B
Revenue—$1.9 B
Net income$-46 M▲ best$-2.8 B
Employees2284,700
Valuation
Price to sales—35.7×
Price to book—10.4×
Free cash flow yield—-2.3%
Profitability
Gross margin—55.4%
Operating margin—-158.1%
Net margin—-145.2%
Return on equity-21.4%▲ best-28.9%
Growth
Revenue growth—-39.9%
Revenue growth, 3 years a year—-53.4%
Financial strength
Debt to equity—0.1×
Cash
Free cash flow margin—-106.2%
Shareholder returns
Shareholder yield—0.0%
Strength scores
Piotroski F-score—3 of 9
Altman Z-score zone—safe
Data as ofMarket cap Jan 2024; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, NovaBridge Biosciences or Moderna, Inc.?

Moderna, Inc. is the larger company by market value: $90.1 B against $177 M for NovaBridge Biosciences, 509 times as much (market caps of Jan 5, 2024 for NovaBridge Biosciences and Oct 30, 2026 for Moderna, Inc.). NovaBridge Biosciences's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, NovaBridge Biosciences or Moderna, Inc.?

Both made a net loss: $46 M for NovaBridge Biosciences and $2.8 B for Moderna, Inc.

Which has more employees, NovaBridge Biosciences or Moderna, Inc.?

Moderna, Inc. employs more people: 4,700 against 228 at NovaBridge Biosciences.

Sources#

Every figure on this page comes from these, with the date shown next to it.